Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

Study Finds Ozempic Linked To Sharp Drop In Depression, Anxiety, And More

Scientists may have just discovered that one of the world’s most talked-about medications has a remarkable hidden benefit. A major new study published in The Lancet Psychiatry has found that GLP-1 medications like semaglutide — the active ingredient in Ozempic, Wegovy, and Rybelsus — are associated with dramatic reductions in depression, anxiety, and substance use disorders. Researchers from the University of Eastern Finland, Karolinska Institutet in Stockholm, and Griffith University in Australia analyzed data from nearly 100,000 individuals tracked through Swedish national health registers over more than a decade. The findings were striking: during periods when participants were taking semaglutide, psychiatric-related hospital visits and sickness absence dropped by 42% compared to periods without the drug. The risk of depression was 44% lower, anxiety disorders were reduced by 38%, and hospital care related to substance use disorders fell by 47%.

The research team notes that while the exact mechanism isn’t yet fully understood, the associations were far stronger than expected. Scientists suspect a combination of factors could be at play — improvements in body image from weight loss, better blood sugar control for diabetes patients, reduced alcohol consumption, and potentially direct effects on the brain’s reward system. “Because this is a registry-based study, we cannot determine exactly why or how these medications affect mood symptoms, but the association was quite strong,” said Research Director Markku Lähteenvuo from the University of Eastern Finland. While more research is needed to fully confirm the link, the study adds to a growing body of evidence that GLP-1 medications that are already celebrated for their impact on obesity, diabetes and heart health, may be quietly reshaping how we think about mental health treatment as well.

Source: https://www.sciencedaily.com/releases/2026/03/260322020250.htm

PrevPreviousThe Happiest Countries On Earth Ranked For 2026
NextJohn Cena’s Viral Hug Reminds The World Why He Is One Of The GreatsNext

Recent Articles

Happy News

For The First Time In History Medicare Is Covering Weight Loss Drugs And The Price Is $50 A Month

May 14, 2026

Starting July 1, 2026 eligible Medicare enrollees will be able to access GLP-1 weight loss medications including Wegovy, Zepbound, and the newer drug Foundayo for a flat $50 monthly copay, in a historic first for the program, which has never before covered anti-obesity medications despite covering many of the serious

Read More
Happy News

Swedish Scientists Just Grew The Cells Type 1 Diabetes Destroys From Scratch

May 13, 2026

Scientists at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed a more reliable method for growing insulin-producing cells from human stem cells, and the results published in Stem Cell Reports represent one of the most encouraging steps yet toward a potential treatment for type 1 diabetes.

Read More
Happy News

New Research Reveals The Personality Trait That Predicts Whether You Will Seek Out A Cat When Stressed

May 12, 2026

A study published in the journal Anthrozoös, conducted by researchers at Washington State University and KU Leuven in Belgium, has identified the personality trait most likely to predict whether someone will seek out a cat for stress relief rather than a dog, and the answer has a name: emotionality. Researchers

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.